Skip to main content

Table 6 People involved in producing a product or delivering a service

From: Evidence-informed health policy 2 – Survey of organizations that support the use of research evidence

Characteristics

Organizations producing CPGs

(n = 31)

Organizations producing HTAs

(n = 19)

Organizations producing CPGs and HTAs

(n = 45)

Organizations supporting government policymaking (n = 57)

Average number of members in a CPG or HTA development panel

1–5 full time equivalents (FTE)

17 (55%)

11 (58%)

23 (51%)

-

6–10 FTE

9 (29%)

5 (26%)

11 (24%)

-

11–15 FTE

2 (6%)

0 (0%)

5 (11%)

-

16–20 FTE

1 (3%)

1 (5%)

1 (2%)

-

> 20 FTE

2 (6%)

1 (5%)

3(7%)

-

Not reported

1 (3%)

1 (5%)

1 (2%)

-

Average number of staff involved in service delivery

< 0.5 full time equivalents (FTE)

-

-

-

8 (14%)

0.5 – 1.9 FTE

-

-

-

6 (11%)

> 2 FTE

-

-

-

37 (65%)

Types of experts/stakeholders who were always involved*

Information/library science

19 (61%)

16 (84%)

27 (60%)

29 (51%)

Clinical epidemiology

21 (68%)

14 (74%)

32 (71%)

24 (42%)

Biostatistics

3 (10%)

6 (32%)

17 (38%)

23 (40%)

Health economics

5 (16%)

10 (53%)

17 (38%)

24 (42%)

Other types of social scientists

4 (13%)

4 (21%)

12 (27%)

23 (40%)

Knowledge transfer/communications

10 (32%)

8 (42%)

21 (47%)

24 (42%)

Consumer

9 (29%)

3 (16%)

17 (38%)

15 (26%)

Other

7 (23%)

9 (47%)

13 (29%)

15 (26%)

Types of experts/stakeholders who were involved only if necessary*

Information/library science

10 (32%)

2 (11%)

13 (29%)

22 (39%)

Clinical epidemiology

8 (26%)

4 (21%)

11 (24%)

22 (39%)

Biostatistics

16 (52%)

12 (63%)

19 (42%)

26 (46%)

Health economics

15 (48%)

9 (47%)

23 (51%)

26 (46%)

Other types of social scientists

14 (45%)

15 (79%)

26 (58%)

24 (42%)

Knowledge transfer/communications

8 (26%)

8 (42%)

9 (20%)

23 (40%)

Consumer

12 (39%)

11 (58%)

11 (24%)

24 (42%)

Other

2 (6%)

4 (21%)

3 (7%)

5 (9%)

Involvement of target users in product development or service delivery

By participation in development/delivery group

25 (81%)

11 (58%)

33 (73%)

-

By survey of views/preferences

9 (29%)

2 (11%)

18 (40%)

-

By review of draft product or service model

22 (71%)

9 (47%)

32 (71%)

-

No

0 (0%)

3 (16%)

3 (7%)

 

Not reported

0 (0%)

2 (11%)

1 (2%)

-

Involvement of consumers (patients or general public) in product development or service delivery

By participation in development group

12 (39%)

3 (16%)

16 (36%)

25 (44%)

By survey of views/preferences

9 (29%)

2 (11%)

14 (31%)

31 (54%)

By review of draft guideline (or HTA)

14 (45%)

5 (26%)

23 (51%)

17 (30%)

No

10 (32%)

9 (47%)

13 (29%)

15 (26%)

Not reported

1 (3%)

2 (11%)

1 (2%)

1 (2%)

Criteria used in expert and/or target user selection*

Geographic balance

21 (68%)

7 (37%)

18 (40%)

-

Gender balance

8 (26%)

2 (11%)

8 (18%)

-

Other

18 (58%)

11 (58%)

25 (56%)

-

  1. *More than one answer was possible for the question